Related Experiment Videos
Angiotensin II activates programmed myocyte cell death in vitro
1Department of Medicine, New York Medical College, Valhalla 10595, USA.
Abstract:
To determine whether angiotensin II (Ang II) can induce apoptosis of neonatal ventricular myocytes, these cells were exposed to 10(-9) M Ang II for 24 h in vitro and the effects of this intervention on programmed myocyte cell death were examined by the terminal deoxynucleotidyl transferase assay and DNA gel electrophoresis. Ang II resulted morphologically in a 2.5-fold increase in the percentage of myocytes with double strand cleavage of the DNA and biochemically in the formation of DNA fragments equal in size to mono- and oligonucleosomes. Moreover, Ang II stimulation was characterized by a 37% increase in resting level of intracellular calcium and the activation of calcium-dependent endogenous endonuclease. In contrast, pH-dependent endogenous endonuclease was not enhanced by the addition of Ang II. Ang II-induced DNA damage was inhibited by the AT1 receptor antagonist, losartan. Similarly, the calcium chelator, BAPTA-AM, prevented Ang II-mediated cell death. Conversely, the calcium ionophore, A23187, triggered programmed cell death. Finally, the selective AT2 receptor subtype blocker, PD123319, failed to reduce myocyte apoptosis. In conclusion, ligand binding of AT1 receptors may initiate programmed myocyte cell death via an elevation in cytosolic calcium and the stimulation of calcium-dependent endogenous endonuclease.
Insights
Angiotensin II (Ang II) triggers programmed cell death in neonatal heart cells by increasing intracellular calcium. This process involves AT1 receptor activation and calcium-dependent enzymes, leading to DNA damage.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Biology
Background:
- Neonatal ventricular myocytes are crucial for heart development.
- Understanding triggers of myocyte cell death is vital for cardiovascular health.
Purpose of the Study:
- To investigate if angiotensin II (Ang II) induces apoptosis in neonatal ventricular myocytes.
- To elucidate the molecular mechanisms underlying Ang II-mediated myocyte apoptosis.
Main Methods:
- Neonatal rat ventricular myocytes were treated with Ang II in vitro.
- Apoptosis was assessed using TUNEL assay and DNA gel electrophoresis.
- Intracellular calcium levels and endonuclease activity were measured.
Main Results:
- Ang II significantly increased DNA double-strand cleavage and DNA fragmentation.
- Ang II elevated intracellular calcium levels and activated calcium-dependent endonuclease.
- AT1 receptor blockade (losartan) and calcium chelation (BAPTA-AM) inhibited Ang II-induced apoptosis.
Conclusions:
- Angiotensin II induces apoptosis in neonatal ventricular myocytes via AT1 receptor activation.
- Elevated cytosolic calcium and activated calcium-dependent endonuclease mediate this process.
- Targeting the AT1 receptor-calcium pathway may offer therapeutic strategies for preventing myocyte loss.